ATE548658T1 - Peptidmarker zur diagnose von präeklampsie - Google Patents

Peptidmarker zur diagnose von präeklampsie

Info

Publication number
ATE548658T1
ATE548658T1 AT08705059T AT08705059T ATE548658T1 AT E548658 T1 ATE548658 T1 AT E548658T1 AT 08705059 T AT08705059 T AT 08705059T AT 08705059 T AT08705059 T AT 08705059T AT E548658 T1 ATE548658 T1 AT E548658T1
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
peptide markers
calcyclin
marker
Prior art date
Application number
AT08705059T
Other languages
English (en)
Inventor
Theo Luider
Smitt Petrus Sillevis
Eric Adrianus Petrus Steegers
Original Assignee
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus Medical Ct filed Critical Univ Erasmus Medical Ct
Application granted granted Critical
Publication of ATE548658T1 publication Critical patent/ATE548658T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08705059T 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie ATE548658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2007/050014 WO2008085024A1 (en) 2007-01-12 2007-01-12 Identification and detection of peptides relating to specific disorders
PCT/NL2008/000021 WO2008085036A1 (en) 2007-01-12 2008-01-14 Peptide markers for diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
ATE548658T1 true ATE548658T1 (de) 2012-03-15

Family

ID=38171286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08705059T ATE548658T1 (de) 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie

Country Status (7)

Country Link
US (2) US20100240088A1 (de)
EP (2) EP2118664B1 (de)
AT (1) ATE548658T1 (de)
AU (2) AU2008203968A1 (de)
CA (2) CA2674736A1 (de)
NZ (1) NZ578262A (de)
WO (4) WO2008085024A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007030930A1 (en) 2005-09-13 2007-03-22 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
KR20180090396A (ko) 2008-01-18 2018-08-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
WO2009158423A1 (en) * 2008-06-25 2009-12-30 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
IT1392551B1 (it) * 2008-11-25 2012-03-09 Bioindustry Park Del Canavese S P A Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica
HRP20191129T1 (hr) 2009-11-24 2019-09-20 Alethia Biotherapeutics Inc. Anti-klusterinska protutijela i ulomci koji vežu antigen i njihova uporaba za smanjivanje volumena tumora
US9595099B2 (en) * 2010-02-26 2017-03-14 Carolyn M Salafia Automated placental measurement
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP4303584A3 (de) 2010-07-23 2024-04-03 President and Fellows of Harvard College Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten
EP2596134B1 (de) 2010-07-23 2020-04-08 President and Fellows of Harvard College Verfahren zur erkennung von erkrankungen oder leiden mit phagozytischen zellen
KR101449100B1 (ko) 2011-04-21 2014-10-13 가톨릭대학교 산학협력단 신경세포 데브리스 제거용 오스테오폰틴
WO2013053359A1 (en) 2011-10-14 2013-04-18 Aarhus Universitet Diagnostic and prognostic use of prombp-complexes
EA201491568A1 (ru) 2012-02-22 2014-11-28 Алетиа Байотерапьютикс Инк. Совместное применение ингибитора кластерина и ингибитора egfr для лечения рака
EP2836832A4 (de) * 2012-04-13 2015-10-14 Univ Wayne State Frühes trimester-screening für früh und spät manifestierte präeklampsie
US20150275298A1 (en) 2012-06-15 2015-10-01 Harry Stylli Methods of detecting diseases or conditions
AU2013273984A1 (en) 2012-06-15 2015-01-22 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
WO2014003853A1 (en) * 2012-06-26 2014-01-03 Biodesix, Inc. Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
EP2965077B1 (de) 2013-03-09 2022-07-13 Harry Stylli Verfahren zur krebserkennung
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
CN115015552A (zh) 2015-06-19 2022-09-06 赛拉预测公司 用于预测早产的生物标志物对
FR3038984B1 (fr) * 2015-07-15 2020-01-10 Universite de Bordeaux Analyse proteomique de compartiments subcellulaires
WO2018151938A2 (en) * 2017-02-17 2018-08-23 The Methodist Hospital Compositions and methods of determining a level of infection in a subject
EP4530633A3 (de) 2017-08-18 2026-03-25 Sera Prognostics, Inc. Schwangerschaftstaktproteine zur vorhersage des frühstadiums und der geburtszeit
WO2019046814A1 (en) 2017-09-01 2019-03-07 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR THE DIAGNOSIS AND MONITORING OF TREATMENT
JPWO2019202767A1 (ja) * 2018-04-17 2021-05-13 国立大学法人大阪大学 抗線維化剤及び線維症のバイオマーカー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
US5436132A (en) * 1993-02-13 1995-07-25 Amano Pharmaceutical Co., Ltd. Quantitative determination of tenascin as glioma marker
ITMI20011833A1 (it) * 2001-08-31 2003-03-03 San Raffaele Centro Fond Agenti che regolano la permeabilita' vascolare
WO2004082455A2 (en) * 2003-03-18 2004-09-30 Biovision Ag Method for detecting alzheimer’s disease and corresponding peptides and detection reagents
JP2008502890A (ja) * 2004-06-18 2008-01-31 エフ．ホフマン−ラ　ロシュ　アーゲー 結腸直腸癌のマーカーとしてのｃｂｐ２の使用
US8841077B2 (en) * 2006-02-28 2014-09-23 Massachusetts General Hospital Biomarkers for amyotrophic lateral sclerosis and methods using the same

Also Published As

Publication number Publication date
US20100291612A1 (en) 2010-11-18
US20100240088A1 (en) 2010-09-23
WO2008085035A1 (en) 2008-07-17
CA2674736A1 (en) 2008-07-17
NZ578262A (en) 2012-02-24
WO2008085036A1 (en) 2008-07-17
AU2008203970A1 (en) 2008-07-17
EP2118664B1 (de) 2012-03-07
EP2118664A1 (de) 2009-11-18
EP2118662A1 (de) 2009-11-18
AU2008203968A1 (en) 2008-07-17
WO2008085024A1 (en) 2008-07-17
WO2008085034A1 (en) 2008-07-17
CA2674737A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
ATE548658T1 (de) Peptidmarker zur diagnose von präeklampsie
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
EP2576839A4 (de) Nukleinsäurenachweis und -quantifizierung durch posthybridisierungs-kennzeichnung und universelle kodierung
EP3636776C0 (de) Verfahren zur analyse von sequenzinformation von nukleinsäuren unter berücksichtigung des gc biases, optional zur diagnose von nukleinsäureanomalien in foeten.
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
EP2054706A4 (de) Verfahren zur erkennung von brechungsindexschwankungen eines ziels
ES2570334T3 (es) Remodelado superficial de proteínas
DE602006018223D1 (de) Verfahren zur Herstellung von Leuchtdioden
CL2007001011A1 (es) Metodo para la identificacion de secretagogos de gip, polipeptido inhibidor gastrico; y uso de un receptor acoplado a proteina g para clasificar compuestos de prueba como secretagogos de gip.
EP2080063A4 (de) Verfahren und formulierung zur elastomer-verstärkung
EP2116642A4 (de) Strickverfahren für fersenteile von socken
EP2333107A4 (de) Genexpressionsprofil als endometrialer rezeptivitätsmarker
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
BR112014021993A2 (pt) detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto
DK2140269T3 (da) Proteinsignatur/markører til at detektere adenocarcinom
EP2390814A3 (de) System und Verfahren für ein übereinstimmendes Muster
BRPI0920989A2 (pt) sistema de criação de plano de combinação e dotação de navio, método e programa para o mesmo
SG191078A1 (en) Improved method and kit for determining severity and progression of periodontal disease
ATE514666T1 (de) Verfahren zur herstellung von ethen
BR112014014279A2 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit
ATE495286T1 (de) Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern
EP1928614A4 (de) Verfahren zur diagnose von infektionen
WO2011003623A3 (de) Verfahren und marker zur individuellen prognose und/oder zur individuellen erfassung einer neuropathie
DE112006001625A5 (de) Verfahren zur Erkennung von Fahrspurmarkierungen
EP2650685A3 (de) Verfahren und Kit zur Klassifizierung und Prognose von Wunden